HCV-1 e2 Protein (484 – 499)

HCV-1 e2 Protein (484 – 499)

HCV-1 e2 Protein (484 – 499)

HCV-1 e2 Protein (484 – 499)

HCV-1 e2 Protein (484 – 499)

HCV-1 E2 Protein (484-499) is a synthetic 16-amino acid peptide antigen corresponding to residues 484-499 of the Hepatitis C Virus genotype 1 (HCV-1) envelope glycoprotein E2. This sequence resides within a critical region of E2 implicated in viral entry and host cell receptor interaction. It is specifically known for containing part of the hypervariable region 1 (HVR1), a highly immunogenic and variable domain involved in immune evasion. 



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
HCV-1 e2 Protein (484–499)
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C88H122N20O19S2
Molecular Weight
1828.19g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, dilute PBS, or DMSO (typically ≥1 mg/mL)

Endotoxin≤1.0 EU/mg
Biological Activity
 Immunogenic peptide fragment of HCV E2 envelope protein, used to study viral entry mechanisms, host immune responses, and the development of HCV vaccines or neutralizing antibody assays.
Storage Conditions
Store at -20°C to -80°C in a dry environment; avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This peptide functions as a specific antigenic target for humoral and cellular immune responses. As part of the E2 glycoprotein, which forms the viral envelope spike with E1, this region is exposed on the surface of the virion and infected cells. Its primary role in vivois to interact with host entry factors. In research, the synthetic peptide acts as a defined antigen:

  1. B-Cell Epitope: It contains linear epitopes that can be recognized by neutralizing and non-neutralizing antibodies. Anti-HCV antibodies in patient serum can bind to this peptide in immunoassays.

  2. T-Cell Epitope: The sequence may contain motifs that can be processed and presented by Major Histocompatibility Complex (MHC) class I or II molecules, potentially stimulating CD8+ or CD4+ T-cell responses.

  3. Receptor Interaction Studies: While a short peptide, it may mimic part of the receptor-binding domain and can be used in competition assays to study the interaction between E2 and entry receptors like CD81 or scavenger receptor class B type I (SR-BI).


    2.PRODUCT INDICATIONS

  • Antibody Detection & Mapping: Used as a coating antigen in Enzyme-Linked Immunosorbent Assay (ELISA) or peptide microarrays to detect and characterize anti-E2 antibodies in patient sera, including mapping the specificity of neutralizing antibodies.

  • Vaccine Research: Evaluating the immunogenicity of this specific E2 region in preclinical vaccine studies. It can be used to assess if antibodies or T-cells induced by a vaccine candidate target this conserved or variable region.

  • Immune Escape Studies: Investigating how sequence variations (mutations) within this HVR1 region affect antibody binding, contributing to the understanding of viral persistence and immune evasion in chronic HCV infection.

  • Receptor Binding Inhibition Assays: As a potential competitive inhibitor, it can be used in in vitroassays to block the interaction between full-length E2 protein and its cellular receptors (e.g., CD81), helping to map critical receptor-binding sites.


    3.CLINICAL EFFICACY OF PRODUCT

  • Research & Diagnostic Tool Efficacy: Its efficacy lies in its ability to reliably detect specific antibody responses and map antigenic sites on the HCV envelope, providing valuable serological and immunological data.

  • Neutralizing Antibody Target: The E2 glycoprotein, and specifically regions including amino acids 484-499, is a major target for broadly neutralizing antibodies (bNAbs). Research using such peptides helps identify conserved, vulnerable sites for antibody-mediated neutralization.

  • Vaccine Development Context: A major goal of HCV vaccine research is to induce potent bNAbs against E2. Defining the exact epitopes, like those within (484-499), that are targeted by such antibodies is critical for rational vaccine design (e.g., using engineered E2 core antigens or peptide immunogens).


  • 4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.